search
Back to results

Using an Adjustable Compression Garment for Secondary Upper Limb Lymphoedema

Primary Purpose

Lymphedema of Upper Arm

Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Manual lymph drainage.
Coban compression bandage..
Adjustable Compression Sleeve
Sponsored by
Institute of Technology, Sligo
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Lymphedema of Upper Arm focused on measuring Breast cancer related lymphoedema., Compression bandaging.

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Upper limb lymphoedema (secondary to breast cancer) diagnosed by a consultant
  • Aged > 18 years.
  • Males and females.
  • Stage 2 Lymphoedema.
  • >10% volume difference between upper limbs.
  • Cognitive ability to understand the programme.

Exclusion Criteria:

  • Involvement in other studies or rehabilitation programmes.
  • Active infection disease progression.
  • Congestive Cardiac Failure.
  • Non-English speakers.
  • Under 18's.
  • Poor cognition for treatment compliance or consent.
  • Pregnant, or currently breast feeding.

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    Active Comparator

    Arm Label

    MLD + Adjustable Compression Sleeve.

    MLD + Coban Compression Bandage.

    Arm Description

    Manual lymph drainage + Adjustable Compression Sleeve.

    Manual lymphatic drainage + Coban compression bandaging.

    Outcomes

    Primary Outcome Measures

    Limb Volume - Circumferential Measurements.
    Limb Volume- circumferential measurements taken at 4cm intervals from the wrist up to the axilla. The circumferences were then entered into a spreadsheet and a truncated cone formula applied with each segment volume calculated: Vs = h(Ct x Ct + Ct x Cb x Cb) 12 π where (Vs) was volume of a segment, (h) was the distance between two points of measurement, (Ct) represented the circumference at the top measurements of the segment, (Cb) represented the circumference at the base of the segment, π = Pi. Once each segment is calculated, the sum of all segments of the arm are computed into a volume estimate. This method was found to be valid (criterion validity)in several studies when compared to the gold standard of water displacement with intra-class correlation coefficient (ICC) of >0.95. The higher the score the more lymphoedema present.
    Short Form 36 (SF-36): Quality of Life questionnaire.
    SF-36 is a set of generic, coherent, and easily administered quality-of-life measures. These measures rely upon patient self-reporting for routine monitoring and assessment of care outcomes in adult patients.It is scored 0-100 with a lower score indicating more disability.

    Secondary Outcome Measures

    Full Information

    First Posted
    June 15, 2020
    Last Updated
    August 5, 2020
    Sponsor
    Institute of Technology, Sligo
    Collaborators
    Sligo General Hospital
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT04435639
    Brief Title
    Using an Adjustable Compression Garment for Secondary Upper Limb Lymphoedema
    Official Title
    Can an Adjustable Compression Garment Replace Compression Bandaging in the Treatment of Patients With Breast Cancer Related Upper Limb Lymphoedema? A Pilot RCT Study
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    August 2020
    Overall Recruitment Status
    Unknown status
    Study Start Date
    October 30, 2020 (Anticipated)
    Primary Completion Date
    April 30, 2021 (Anticipated)
    Study Completion Date
    January 31, 2022 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    Institute of Technology, Sligo
    Collaborators
    Sligo General Hospital

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    This is a pilot randomised controlled trial investigating the use of an adjustable compression garment in the treatment of patients with Breast Cancer related upper limb Lymphoedema. This study will be conducted as part of a MSc qualification at the Institute of Technology Sligo in Ireland with all therapy sessions taking place in the Physiotherapy Department of Sligo University Hospital (formerly Sligo General Hospital). The study will be conducted in conjunction with Sligo University Hospital and it has attained ethical approval through the relevant University Hospital Ethics Committee.
    Detailed Description
    The experimental group will receive 5 treatments followed by a final assessment on the 6th visit over a 3 week period: participants will receive manual lymphatic drainage for 40 minutes. They will then put on an Adjustable Compression sleeve (Juzo varocare adjustable compression system). Patients will be re-measured before the fourth treatment and again on session 6. At this point patients will receive a standard arm compression sleeve. This will be worn in alternation with their adjustable compression sleeve over the following 6 months. Patient will have their limb volume re-measured at the 6 month review. The control group will receive 5 treatments followed by a final assessment on the 6th visit over a 3 week period: participants will receive manual lymphatic drainage for 40 minutes. They will then have their arm wrapped in Coban compression bandaging which will stay on until their next treatment. This will occur twice weekly for a period of 3 weeks. Patients will be Re-measured before the fourth treatment and again on session 6. At this point they will attend occupational therapy where they will receive 2 standard arm compression sleeves. The patient wears 1 sleeve every day over the following 6 months. Patient will have their limb volume re-measured at the 6 month review.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Lymphedema of Upper Arm
    Keywords
    Breast cancer related lymphoedema., Compression bandaging.

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Model Description
    Pilot Randomised Controlled Trial
    Masking
    Outcomes Assessor
    Masking Description
    Outcome assessor was blinded to treatment allocation. They evaluated participant's prior to treatment commencing and after treatment has been completed and compression garment/ compression bandaging has been removed.
    Allocation
    Randomized
    Enrollment
    30 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    MLD + Adjustable Compression Sleeve.
    Arm Type
    Experimental
    Arm Description
    Manual lymph drainage + Adjustable Compression Sleeve.
    Arm Title
    MLD + Coban Compression Bandage.
    Arm Type
    Active Comparator
    Arm Description
    Manual lymphatic drainage + Coban compression bandaging.
    Intervention Type
    Other
    Intervention Name(s)
    Manual lymph drainage.
    Intervention Description
    Manual Lymphatic drainage: Patients will receive manual lymphatic drainage by massage for 40 minutes for 5 treatments over a 15 day period.
    Intervention Type
    Procedure
    Intervention Name(s)
    Coban compression bandage..
    Intervention Description
    Coban compression bandaging: Patients will be wrapped in Coban compression bandaging which stays on until the next treatment. Patients will wear standard compression sleeves during the six month maintenance phase.
    Intervention Type
    Device
    Intervention Name(s)
    Adjustable Compression Sleeve
    Intervention Description
    Patients wear an adjustable compression sleeve (Juzo varocare adjustable compression system) between treatments. They will be shown how to put it on and how to tighten the sleeve when needed. Patients will also wear the adjustable compression sleeve in alternation with a standard compression sleeve over a six month maintenance phase.
    Primary Outcome Measure Information:
    Title
    Limb Volume - Circumferential Measurements.
    Description
    Limb Volume- circumferential measurements taken at 4cm intervals from the wrist up to the axilla. The circumferences were then entered into a spreadsheet and a truncated cone formula applied with each segment volume calculated: Vs = h(Ct x Ct + Ct x Cb x Cb) 12 π where (Vs) was volume of a segment, (h) was the distance between two points of measurement, (Ct) represented the circumference at the top measurements of the segment, (Cb) represented the circumference at the base of the segment, π = Pi. Once each segment is calculated, the sum of all segments of the arm are computed into a volume estimate. This method was found to be valid (criterion validity)in several studies when compared to the gold standard of water displacement with intra-class correlation coefficient (ICC) of >0.95. The higher the score the more lymphoedema present.
    Time Frame
    Over a 6 month period. (10 min testing time)
    Title
    Short Form 36 (SF-36): Quality of Life questionnaire.
    Description
    SF-36 is a set of generic, coherent, and easily administered quality-of-life measures. These measures rely upon patient self-reporting for routine monitoring and assessment of care outcomes in adult patients.It is scored 0-100 with a lower score indicating more disability.
    Time Frame
    Over a 6 month period. (10 min testing time)

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Upper limb lymphoedema (secondary to breast cancer) diagnosed by a consultant Aged > 18 years. Males and females. Stage 2 Lymphoedema. >10% volume difference between upper limbs. Cognitive ability to understand the programme. Exclusion Criteria: Involvement in other studies or rehabilitation programmes. Active infection disease progression. Congestive Cardiac Failure. Non-English speakers. Under 18's. Poor cognition for treatment compliance or consent. Pregnant, or currently breast feeding.
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Kenneth Monaghan, PhD
    Phone
    0879480448
    Email
    monaghan.kenneth@itsligo.ie
    First Name & Middle Initial & Last Name or Official Title & Degree
    Shane Gallagher, MSc
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Shane Gallagher, MSc
    Organizational Affiliation
    Study Principal Investigator
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Learn more about this trial

    Using an Adjustable Compression Garment for Secondary Upper Limb Lymphoedema

    We'll reach out to this number within 24 hrs